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Malonyl-CoA-acyl carrier protein transacylase (MCAT) transfers the malonyl group from malonyl-
CoA to holo-acyl carrier protein (ACP), and since malonyl-ACP is a key building block for fatty-acid
biosynthesis it is considered as a promising antibacterial target. The crystal structures of MCAT from
Staphylococcus aureus and Streptococcus pneumoniae have been determined at 1.46 and 2.1 Å reso-
lution, respectively. In the SaMCAT structure, the N-terminal expression peptide of a neighboring
molecule running in the opposite direction of malonyl-CoA makes extensive interactions with the
highly conserved ‘‘Gly-Gln-Gly-Ser-Gln” stretch, suggesting a new design platform. Mutagenesis
results suggest that Ser91 and His199 are the catalytic dyad.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The biosynthesis of fatty acids is a fundamental component of
the cellular metabolic pathway, since fatty acids are the essential
building blocks for membrane phospholipid formation [1–3]. Most
bacteria and plants synthesize fatty acids using a discrete and
highly conserved group of enzymes called the type II fatty acid syn-
thase (FAS II) system while yeast and animals utilize the type I
fatty acid synthase (FAS I) which consists of a polypeptide about
270 kDa in size with multiple active sites that perform all the cat-
alytic reactions in the pathway. FAS II is a dissociated system
wherein each component is encoded by a separate gene. Due to
these differences the enzymes in the type II FAS system have re-
ceived enormous attention as possible antibiotic targets [4–6].
Malonyl-ACP is the key building block for fatty-acid biosynthe-
sis, and malonyl-CoA-acyl carrier protein transacylase (MCAT;
EC2.3.1.39), also known as FabD, transfers the malonyl group from
malonyl-CoA to the holo-acyl carrier protein (ACP) forming malo-
nyl-ACP and free CoA-SH [7], therefore it is one of the key enzymeschemical Societies. Published by E
protein transacylase; CoA,
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m).in the FAS II system. Genetic inactivation of the fabD gene has been
shown to be lethal in all major pathogens investigated. It has only a
single isoform reported [8] and a continuous coupled enzyme as-
say has been developed [9]. In addition, crystal structures of MCAT
from Escherichia coli [10,11], and Streptomyces coelicolor [12], H. py-
lori [13] and M. tuberculosis [14] have been reported. These all sug-
gest that MCAT is one of the most promising targets. However, thus
far only a limited number of inhibitors have been reported [15],
and new insight of the active site is much needed.
Here, we report the crystal structure of MCAT from Staphylococ-
cus aureus (denoted as SaMCAT) and Streptococcus pneumoniae (de-
noted as SpnMCAT) which are major pathogens. The SpnMCAT
structure includes an acetate ion at the active site while SaMCAT
has a sulfate ion as well as the N-terminal expression peptide of
a neighboring protein molecule at the entrance to the active site.
Structural information obtained here could be applied in the inhib-
itor design.
2. Materials and methods
2.1. Gene cloning, protein expression, and puriﬁcation
SaMCAT was overexpressed, puriﬁed as described previously
[16]. SpnMCAT was ampliﬁed from the genomic DNA using PCR,
and the PCR products were ligated into the pET22b vector system
(Novagen). The enzyme was overexpressed in E. coli BL21 (DE3)lsevier B.V. All rights reserved.
Table 1
Statistics on the data collection and structure reﬁnement.
SaMCAT SpnMCAT
Data collection statistics
X-ray source Pohang Light Source (PLS),
bemaline 4A (BL-4A)
Rigaku, RAXIS IV++
Wavelength (Å) 1.0000 1.5418
Space group P21 P212121
Unit cell parameters
a (Å) 42.16 48.26
b (Å) 87.91 63.51
c (Å) 43.24 89.89
a, b, k () a = c = 90, b = 103.995 a = b = c = 90
Resolution range (Å) 50–1.46 (1.51–1.46) 20–2.00 (2.07–2.00)
Total no. of reﬂection 848 806 99 009
No. of unique reﬂection 52 963 18 662
Completeness (%) 90.4 (76.2) 97.0 (79.2)
I/r(I) 31.1 (2.7) 16.0 (3.3)
Rmerge
a (%) 3.4 (18.9) 6.0 (21.4)
Reﬁnement statistics
Resolution range (Å) 50–1.46 20–2.1
R-value/Rfreeb (%) 15.7/18.4 21.2/27.0
No. of protein atoms 2395 2321
No. of water molecules 218 134
No. of ligand atoms 10 4
RMSD from ideal geometry
Bond lengths (Å) 0.028 0.028
Bond angles () 2.21 1.83
a Rmerge =
P
h
P
i|I(h, i)  hI(h)i|/
P
h
P
iI(h, i), where I(h, i) is the intensity of the ith
measurement of reﬂection h and hI(h)i is the mean value of I(h, i) for all i
measurements.
b Rfree is calculated from the randomly selected 5% set of reﬂections not included
in the calculation of the R-value.
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50 mM NaCl, 1 mM MgCl2, 2% glycerol and 0.2 mM PMSF. After
centrifugation, MCAT in the supernatant was puriﬁed using Ni2+-
chelated Hi-trap chelating column, followed by a Q-sepharose col-
umn and a HiLoad 26/60 75pg column (Amersham Biosciences,
Sweden). After the ﬁnal puriﬁcation step both SaMCAT and
SpnMCAT were stored in 20 mM Tris–HCl (pH 7.5), 100 mM NaCl,
and 1 mM TCEP.Fig. 1. (A) Ribbon and (B) surface representation of malonyl-CoA-acyl carrier protein tra
SaMCAT (blue) that showed the largest structural difference from SpnMCAT (yellow), EcM
box viewed at a different angle for clarity. Charge-distribution surface with red and blue
from EcMACT(PDB code: 2G2Z) is included.2.2. Crystallization and data collection
Crystals were obtained using the hanging-drop vapor-diffusion
method by mixing an equal volume of protein solution with reser-
voir solution. SaMCAT crystals were obtained by mixing 15 mg/ml
protein solution and reservoir with 21–23% PEG3350, 0.5–0.52 M
calcium acetate (pH 7.3) at 22 C, and the crystals appeared in 5
days. SpnMCAT crystals were grown from 18 mg/ml protein solu-
tion and a reservoir consisting of 8–16% PEG8000, 0.2 M calcium
acetate and 0.1 M sodium cacodylate (pH 6.5) at 4 C. Diffraction
data were collected at 100 K with an ADSC Quantum CCD detector
(Madison, WI, USA) at the 4A beamline of Pohang Light Source
(PLS), and RAXIS IV++ image plate system with Rigaku RU200 rotat-
ing anode generator, and processed using the program HKL2000
[17] and Crystal Clear™ version 1.3, respectively. Details of data
are given in Table 1.
2.3. Structure determination and reﬁnement
An initial model for SaMCAT was obtained using the molecular
replacement program MOLEP with EcMCAT (PDB code 1MLA) as a
model while SpnMCAT was solved using the SaMCAT structure.
Reﬁnements were carried out using the program CNS [18] and
CCP4 [19] suite while model were built using the program COOT
[20]. Statistics on the ﬁnal model are given in Table 1. The ﬁnal
structures were evaluated with the program PROCHECK [21] and
ﬁgures were generated using Pymol (http://pymol.source-
forge.net/) and Espript (http://espript.ibcp.fr/ESPript/ESPript/).
The coordinates and structure factors of SaMCAT and SpnMCAT
have been deposited in the RCSB Protein Data Bank with the acces-
sion numbers 3IM9 and 3IM8, respectively.
2.4. Coupled enzymatic assay
The enzymatic activity was measured following the previously
reported a-ketoglutarate dehydrogenase (KDH)-coupled assay sys-
tem [9,15,22]. Brieﬂy, KDH-dependent consumption of coenzyme A
(CoA) generated by MCAT is accompanied by a reduction of nico-
tinamide adenine dinucleotide (NAD+) to NADH and the rate of
NADH production is measured with the excitation wavelengthnsacylase from S. aureus (SaMCAT). The two are in the same orientation. The helix 8
CAT (pink, PDB code: 2G2O) and MtMCAT (green, PDB code: 2QC3) is shown in the
areas represent the negatively and positively charged surface, respectively. The CoA
Fig. 2. (A) Active site of SpnMCAT (yellow) and EcSaMCAT (pink). Acetate ion bound to active site of SpnMCAT is shown using the ball and stick representation. (B) Sequence
alignment of SpnMCAT, SaMCAT, MtMCAT and EcMCAT for the residues near the active site. The secondary structure of SpnMCAT is shown above the sequence with the
catalytic residues indicated with a star while the key residues at the active site are indicated with blue triangles at the bottom of the sequence. (C) Relative activity of active
site mutants of SpnMCAT. The mutants were expressed with N-terminal histidine expression tag and puriﬁed in the same manner as the wild type. N-His and C-His refer to
the wild type enzymes with the histidine tag at the N- and the C-terminal of the enzyme, respectively. The enzymatic activity was measured using the KDH-coupled assay.
1242 S.K. Hong et al. / FEBS Letters 584 (2010) 1240–1244set at 340 nm and emission wavelength at 465 nm using a ﬂuores-
cence spectrometer LS50B. The ﬁnal concentrations of reaction
mixture were 50 mM phosphate buffer (pH 6.8), 1 mM EDTA,
1 mM DTT, 2 mM a-ketoglutarate, 0.25 mM NAD+, 0.2 mM TPP,
90 mU/100 ll KDH, 10 lM ACP, 25 lM malonyl-CoA, and 3 nM of
SpnMCAT.3. Results and discussion
3.1. Overall structure of SaMCAT and SpnMCAT
The crystal structures of MCAT from S. aureus and S. pneumoniae
have been determined at 1.46 and 2.1 Å, and reﬁned to R-values of
Fig. 3. The N-terminal expression peptide of a neighboring molecule bound at the active site pocket in SaMCAT. (A) Conserved residues are colored in green and the two
stretches of the signature sequence (‘‘Gly-Gln-Gly-ser-Gln” and ‘‘Gly-his-Ser-leu-Gly-Glu”) are highlighted in magenta. The electron density for the expression peptide is
contoured at 1.0r level. (B) The residues involved in the interaction with the expression peptide are shown in blue.
S.K. Hong et al. / FEBS Letters 584 (2010) 1240–1244 124315.7% and 21.2%, respectively. All atoms are well deﬁned in the
electron density maps. As shown in Fig. 1A both share the same
overall structure which is composed of two ab sub-domains con-
nected by two linkers. The large sub-domain consists of the six
b-stranded central b-sheet surrounded by 11 helices while the
small sub-domain (SaMCAT:122–200 and SpnMCAT:123–200) con-
sists of a four-stranded anti-parallel b-sheet capped by two helices.
The structures described here are similar to those reported for
EcMCAT [10,11], ScMCAT [12], HpMCAT [13] and MtMCAT [14].
The sequence identities are about 28–35%. However, the relative
orientation of the two domains varies from one another (see
Fig. 1A). In particular, the small sub-domain of SaMCAT is shifted
outwards signiﬁcantly. For example, the helix 8 of SaMCAT shows
an RMSD of 1.39 Å from that of EcMCAT, while SpnMCAT shows an
RMSD of only 0.35 Å.
Both SaMCAT and SpnMCAT have positive patches on both large
and small domains that are about 15 Å away from the catalytic ser-
ine (Fig. 1B). Similar positive patches are also observed in other
MCAT structures; they are expected to interact with the highly
negatively charged surfaces of ACP [12,13,23].
3.2. Active site and mechanism based on SpnMCAT mutants
The active site is located at the interface between the two sub-
domains (Fig. 1B), and the catalytic Ser (SaMCAT:89 and
SpnMCAT:90) with the signature sequence ‘‘Gly-His-Ser-leu-Gly-
Glu” is at the bottom of the gorge. The generally accepted mecha-
nism can be described in two steps. First, malonyl-CoA is bound
and the malonyl moiety is transferred to the catalytic serine with
CoA released. Then ACP binds and the malonyl moiety is trans-
ferred to the terminal sulfhydryl of the ACP prosthetic group. Thereaction is reversible and is highly speciﬁc for malonyl-CoA. This
acyl transferase belongs to the ab hydrolase super-family but with
catalytic serine and nearby histidine serving as the catalytic dyad.
The bound malonate is stabilized by the side-chain of Arg, and
backbone amide of Gln and Leu at the active site, but the details
of the mechanism have not been unequivocal [10–12,24]. The most
pronounced discrepancy is the identiﬁcation of the catalytic resi-
due. Ser91 and the proceeding His90 were suggested as the cata-
lytic dyad in MtMCAT (Fig. 2B) [14].
3.3. Mutagenesis study on the catalytic residues
In SaMCAT and SpnMCAT, all the residues that are reported to
be critical in the enzymatic reaction, namely Gln (SaMCAT:11
and SpnMCAT:11), Arg (SaMCAT:114 and SpnMCAT:115), and His
(SaMCAT:199 and SpnMCAT:199), are found in similar positions
with the exception of the histidine proceeding the catalytic serine
(SaMCAT:89 and SpnMCAT:90) as seen in Fig. 2A and B. It is histi-
dine in SaMAT as seen in others, however, in SpnMCAT this is re-
placed by a leucine residue. This was surprising as this histidine
residue was thought to be part of the signature sequence for mal-
onyl transferases. In fact a blast search shows that MCATs in a
number of microbes such as S. pyogens, E. faecalis, C. tetani and B.
cereus have leucine at this position. In order to conﬁrm the residues
involved in catalysis, we carried out a mutagenesis study using
SpnMCAT. As seen in Fig. 2C the Leu89Ala mutant shows almost
the same activity as the wild type, while His199Ala mutant showed
a drastic reduction in activity indicating that it is His199 that is
part of the catalytic machinery. In addition, a reduction in activity
is also observed for the Arg115Ala mutant, supporting the earlier
suggestion that Arg stabilizes the bound malonate. The acetate
1244 S.K. Hong et al. / FEBS Letters 584 (2010) 1240–1244found in the SpnMCAT structure (see Fig. 2A) is positioned too far
from the guanidinium moiety of Arg115 to make a direct interac-
tion, but it makes hydrogen bonds to the backbone amide of
Leu91 and Ne of His199. Another interesting point is the reduction
in activity seen by Phe198Ser mutant. Previous studies have sug-
gested that this phenylalanine and nearby methionine (SaM-
CAT:118 and SpnMCAT:119) play a role as a selective ﬁlter that
governs the substrate speciﬁcity in ScMCAT [12,22]. In EcMCAT
methionine and serine are found at these positions.
3.4. New platform for inhibitor design
Our attempts to soak substrate analogs and small molecules
failed with the exception of the acetate mentioned above. None-
theless, in SaMCAT the unprocessed N-terminal expression peptide
of a neighboring molecule is found inserted near the active site. In
addition, a sulfate ion is located between the expression peptide
and the imidazole ring of His88. The peptide includes His-Ser-
Ser-Gly-Leu-Val-Pro-Arg-Gly-Ser-His-Met prior to Ala5 of SaMCAT,
and these make extensive interactions with the residues leading to
the active site. The buried surface area between the two neighbor-
ing molecules is 1380 Å2 which is about 10% of total surface area of
one molecule. The opening of the small domain mentioned above is
possibly due to this peptide binding.
As seen in Fig. 3, the expression peptide is running in almost the
opposite direction of malonyl-CoA seen in the complex structure
with EcMCAT (Fig. 1B) [11]. The expression peptide is in contact
with the residues that are highly conserved, shown in green in
Fig. 3A. In particular, Gly-4 and Val-2 of the expression peptide
make van der Waals interactions with the second signature stretch,
‘‘Gly-Gln-Gly-ser-Gln” which is highlighted in magenta in Fig. 3A.
Also Leu-3 interacts with Met190 and Leu192, while Arg0 making
a salt bridges with Asp175 as well as hydrogen bonds to Pro191
and Ser128 (Fig. 3B). Together, with the bound sulfate ion, these
hydrophobic interactions can be exploited for new inhibitor design.
In summary, we have determined the structures of MCAT from
S. aureus and S. pneumoniae, and we believe that these structures
provide useful information for the design of novel inhibitors. In
addition, the enzymatic activities of the SpnMCAT mutants suggest
that Ser90 and His199 are the catalytic dyad with Arg115 and
Phe198 playing critical roles in catalysis.
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